Redeye comments on Fable Media Group's proposal to distribute SEK 0.
Physitrack’s board has announced its intention to implement a share buyback program (SBB) for up to ...
Hyresintäkterna steg 6,8% till 478,5 mkr drivet av indexeringar och uthyrningsgrad 99% (97%).
* +7% organic growth y-o-y, -1% vs. ABGSCe * 13% adj.
Train Alliance's Q4 looks stable. Sale of land area in Hallsberg generated profit of SEK 44.
* Sales -9% but adj. EBITA +7% vs. consensus * Margin improvement supported by cost efforts and Habb...
Redeye expects a negative share price reaction to InfraCom's Q4 2025 results.
Xbrane's year-end report showed lower revenue, consisting almost exclusively of delieveries to STADA...
Redeye comments on Formpipe’s Q4 report, which shows weak ACV but solid profitability.
Seafire delivered 11% organic sales growth, improved earnings, strong cash flow, and reduced leverag...
Following the breakthrough license deal with Moderna, a global leader in mRNA therapeutics, in Q4’25...
Carlsquare Equity Research har publicerat en analysuppdatering på Angler Gaming efter kv4 2025.
* An EBIT increase to SEK 6m (3m) in Q4'25 * We raise EBIT by 2-3% for '26e-'27e * Well positioned f...
BICO’s Q4 report broadly aligned with our estimates, showing slightly negative organic growth and ad...
Net sales and adj. EBITA were slightly below market consensus (LSEG) in Q4.
Redeye updates on G5 Entertainment following weaker-than-expected Q4 results and continued uncertain...
Redeye updates its estimates and valuation after OEM’s Q4 2025 report.
Redeye views Q4 as a soft but expected quarter, fully explained by Brazil.
Recent years have been quite volatile for Incap. Quarterly revenue growth fluctuated between +40% an...
Redeye comments on Magle’s profit warning ahead of its Q4 and full-year 2025 results, which we see a...
